These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9608250)

  • 1. [Therapeutic strategy in advanced breast carcinoma].
    Kaufmann M; von Minckwitz G; Costa S
    Praxis (Bern 1994); 1998 Apr; 87(15):529-30. PubMed ID: 9608250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for advanced breast cancer: a current perspective.
    Seidman AD
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):55-9. PubMed ID: 8614846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study.
    Montero AJ; Rouzier R; Lluch A; Theriault RL; Buzdar AU; Delaloge S; Bermejo B; Le M; Kau SW; Dunant A; Arriagada R; Spielmann M; Garcia-Conde J; Sahin AA; Singletary SE; Hortobagyi GN; Valero V
    Cancer; 2005 Jul; 104(2):229-35. PubMed ID: 15937910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies with high-dose chemotherapy and subsequent autologous stem cell transplantation in breast carcinoma].
    Nitz U; Adomeit A; Mohrmann S; Fossari A; Frick M
    Praxis (Bern 1994); 1998 Apr; 87(17):578-83. PubMed ID: 9623324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and outcomes of isolated axillary node recurrence in breast cancer.
    Konkin DE; Tyldesley S; Kennecke H; Speers CH; Olivotto IA; Davis N
    Arch Surg; 2006 Sep; 141(9):867-72; discussion 872-4. PubMed ID: 16983030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: influence of clinical presentation on outcome.
    Geara FB; Nasr E; Tucker SL; Charafeddine M; Dabaja B; Eid T; Abbas J; Salem Z; Shamseddine A; Issa P; El Saghir N
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):364-9. PubMed ID: 17324529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
    Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
    Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma.
    Huston TL; Pressman PI; Moore A; Vahdat L; Hoda SA; Kato M; Weinstein D; Tousimis E
    Breast J; 2007; 13(2):158-64. PubMed ID: 17319857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic strategy in breast cancer].
    Florea I; Dragomirescu C; Aldea C; Mihai C; Lişcu B; Liţescu M; Pento V; Vizeteu R
    Chirurgia (Bucur); 1995; 44(4):7-15. PubMed ID: 8646030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiotherapy of breast carcinoma. 2005 version].
    Organgruppe "Mammakarzinom" der DEGRO
    Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
    [No Abstract]   [Full Text] [Related]  

  • 14. Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation.
    Stranzl H; Mayer R; Ofner P; Peintinger F; Prettenhofer U; Hackl A
    Strahlenther Onkol; 2004 Jan; 180(1):31-7. PubMed ID: 14704842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effective treatment strategy in elderly breast cancer patients].
    Boér K
    Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients.
    Kennedy T; Stewart AK; Bilimoria KY; Patel-Parekh L; Sener SF; Winchester DP
    Ann Surg Oncol; 2007 Oct; 14(10):2918-27. PubMed ID: 17638060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications.
    Karlsson YA; Malmström PO; Hatschek T; Fornander TG; Söderberg M; Bengtsson NO; Jansson TE; Sjöberg SM; Bergh JC
    Cancer; 1998 Sep; 83(5):936-47. PubMed ID: 9731898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.